United States Biotechnology & Medical Research

Century Therapeutics Inc (IPSC)

Track

Track

Century Therapeutics experienced exclusively selling activity over the recent period, with executives disposing of shares totaling over 19,000 USD. These transactions occurred alongside a challenging earnings report where the company missed expectations. Stock performance remains relatively flat, reflecting broader market trends within the healthcare sector.
Ticker: IPSC Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Century Therapeutics Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
3.9
Carr Douglas SVP Finance & Operations Officer
Transaction date
Sale
Price
19.59
Quantity 12,941 +46.3%
Value US$4,742,559
3.7
Russotti Gregory See Remarks Officer
Transaction date
Sale
Price
277.88
Quantity 87,296 +21.6%
Value US$1,966,921
3.9
Carr Douglas SVP Finance & Operations Officer
Transaction date
Sale
Price
286.52
Quantity 16,488 +24.1%
Value US$2,098,316
3.7
Russotti Gregory Officer Officer
Transaction date
Proposed sale
Price
2.23
Quantity 2,584
Value US$5,768
3.9
Carr Douglas SVP Finance & Operations Officer
Transaction date
Sale
Price
2.11
Quantity 249 -0.0%
Value US$526
3.9
Carr Douglas SVP Finance & Operations Officer
Transaction date
Sale
Price
2.11
Quantity 249 -0.0%
Value US$526
3.7
Russotti Gregory See Remarks Officer
Transaction date
Sale
Price
2.11
Quantity 524 -0.1%
Value US$1,106
3.7
Russotti Gregory Officer Officer
Transaction date
Proposed sale
Price
2.11
Quantity 524
Value US$1,106
3.9
Carr Douglas SVP Finance & Operations Officer
Transaction date
Sale
Price
2.34
Quantity 264 -0.1%
Value US$618
3.7
Russotti Gregory See Remarks Officer
Transaction date
Sale
Price
2.55
Quantity 10,076 -1.9%
Value US$25,684
3.9
Carr Douglas SVP Finance & Operations Officer
Transaction date
Sale
Price
2.55
Quantity 7,043 -1.4%
Value US$17,953
3.7
Russotti Gregory Officer Officer
Transaction date
Proposed sale
Price
2.55
Quantity 10,076
Value US$25,686
3.9
Carr Douglas SVP Finance & Operations Officer
Transaction date
Sale
Price
2.54
Quantity 247 -0.0%
Value US$626
3.7
Russotti Gregory See Remarks Officer
Transaction date
Sale
Price
2.54
Quantity 479 -0.1%
Value US$1,215
3.7
Russotti Gregory Officer Officer
Transaction date
Proposed sale
Price
2.54
Quantity 479
Value US$1,215
3.9
Carr Douglas SVP Finance & Operations Officer
Transaction date
Sale
Price
1.82
Quantity 323 -0.1%
Value US$589
3.5
Cowan Chad Chief Scientific Officer Officer
Transaction date
Purchase
Price
0.85
Quantity 58,060 +5.9%
Value US$49,252
4.0
Pfeiffenberger Brent President and CEO Executive Director
Transaction date
Purchase
Price
0.58
Quantity 52,000 +1.6%
Value US$30,352
3.7
Russotti Gregory See Remarks Officer
Transaction date
Sale
Price
0.53
Quantity 526 -0.1%
Value US$280
3.9
Carr Douglas SVP Finance & Operations Officer
Transaction date
Sale
Price
0.53
Quantity 257 -0.1%
Value US$137
4.0
Pfeiffenberger Brent Officer; Director Executive Director
Transaction date
Proposed sale
Price
0.53
Quantity 476
Value US$253
3.7
Russotti Gregory Officer Officer
Transaction date
Proposed sale
Price
0.53
Quantity 526
Value US$280
3.5
Cowan Chad Chief Scientific Officer Officer
Transaction date
Sale
Price
0.50
Quantity 5,462 -0.6%
Value US$2,736
3.5
Cowan Chad Officer Officer
Transaction date
Proposed sale
Price
0.50
Quantity 5,462
Value US$2,739
4.0
Pfeiffenberger Brent President and CEO Executive Director
Transaction date
Purchase
Price
0.50
Quantity 35,000 +1.1%
Value US$17,328
4.0
Pfeiffenberger Brent President and CEO Executive Director
Transaction date
Sale
Price
0.45
Quantity 32,456 -1.0%
Value US$14,735
4.0
Pfeiffenberger Brent Officer; Director Executive Director
Transaction date
Proposed sale
Price
0.45
Quantity 32,456
Value US$14,732
3.9
Carr Douglas SVP Finance & Operations Officer
Transaction date
Sale
Price
0.59
Quantity 292 -0.1%
Value US$171
3.9
Carr Douglas SVP Finance & Operations Officer
Transaction date
Sale
Price
0.50
Quantity 263 -0.1%
Value US$132
4.0
Pfeiffenberger Brent President and CEO Executive Director
Transaction date
Sale
Price
0.50
Quantity 488 -0.0%
Value US$244
3.7
Russotti Gregory See Remarks Officer
Transaction date
Sale
Price
0.50
Quantity 539 -0.1%
Value US$270
4.0
Pfeiffenberger Brent Officer; Director Executive Director
Transaction date
Proposed sale
Price
0.50
Quantity 488
Value US$244
3.7
Russotti Gregory Officer Officer
Transaction date
Proposed sale
Price
0.50
Quantity 539
Value US$269
4.0
Pfeiffenberger Brent Officer; Director Executive Director
Transaction date
Proposed sale
Price
0.57
Quantity 30,745
Value US$17,522
3.9
Carr Douglas SVP Finance & Operations Officer
Transaction date
Sale
Price
0.53
Quantity 296 -0.1%
Value US$158
4.0
Pfeiffenberger Brent President and CEO Executive Director
Transaction date
Sale
Price
0.62
Quantity 475 -0.0%
Value US$295
3.9
Carr Douglas SVP Finance & Operations Officer
Transaction date
Sale
Price
0.62
Quantity 4,904 -1.2%
Value US$3,050
3.6
Farid Adrienne Chief Operations Officer Officer
Transaction date
Sale
Price
0.62
Quantity 552 -0.2%
Value US$343
3.7
Russotti Gregory See Remarks Officer
Transaction date
Sale
Price
0.62
Quantity 526 -0.1%
Value US$327
4.0
Pfeiffenberger Brent Officer; Director Executive Director
Transaction date
Proposed sale
Price
0.62
Quantity 475
Value US$296
3.6
Farid Adrienne Officer Officer
Transaction date
Proposed sale
Price
0.62
Quantity 552
Value US$343
3.7
Russotti Gregory Officer Officer
Transaction date
Proposed sale
Price
0.62
Quantity 526
Value US$327
4.0
Pfeiffenberger Brent President and CEO Executive Director
Transaction date
Sale
Price
0.55
Quantity 29,552 -1.7%
Value US$16,135
4.0
Pfeiffenberger Brent Officer; Director Executive Director
Transaction date
Proposed sale
Price
0.55
Quantity 29,552
Value US$16,138
3.6
Farid Adrienne Chief Operations Officer Officer
Transaction date
Sale
Price
0.55
Quantity 1,024 -0.4%
Value US$563
3.9
Carr Douglas SVP Finance & Operations Officer
Transaction date
Sale
Price
0.55
Quantity 295 -0.1%
Value US$162
3.6
Farid Adrienne Officer Officer
Transaction date
Proposed sale
Price
0.55
Quantity 1,024
Value US$563
4.0
Pfeiffenberger Brent President and CEO Executive Director
Transaction date
Sale
Price
0.62
Quantity 2,235 -0.2%
Value US$1,375
3.6
Farid Adrienne Chief Operations Officer Officer
Transaction date
Sale
Price
0.62
Quantity 2,359 -1.8%
Value US$1,451
3.9
Carr Douglas SVP Finance & Operations Officer
Transaction date
Sale
Price
0.62
Quantity 1,240 -0.4%
Value US$763
3.7
Russotti Gregory See Remarks Officer
Transaction date
Sale
Price
0.62
Quantity 2,360 -0.9%
Value US$1,451
4.0
Pfeiffenberger Brent Officer; Director Executive Director
Transaction date
Proposed sale
Price
0.62
Quantity 2,235
Value US$1,375
3.7
Russotti Gregory Officer Officer
Transaction date
Proposed sale
Price
0.62
Quantity 2,360
Value US$1,452
3.6
Farid Adrienne Officer Officer
Transaction date
Proposed sale
Price
0.62
Quantity 2,359
Value US$1,451
4.0
Pfeiffenberger Brent President and CEO Executive Director
Transaction date
Sale
Price
0.78
Quantity 34,712 -2.8%
Value US$27,179
4.0
Pfeiffenberger Brent Officer; Director Executive Director
Transaction date
Proposed sale
Price
0.78
Quantity 34,712
Value US$27,166
3.9
Carr Douglas SVP Finance & Operations Officer
Transaction date
Sale
Price
0.78
Quantity 351 -0.1%
Value US$274
3.6
Farid Adrienne Chief Operations Officer Officer
Transaction date
Sale
Price
0.78
Quantity 1,054 -0.8%
Value US$822
3.6
Farid Adrienne Officer Officer
Transaction date
Proposed sale
Price
0.78
Quantity 1,054
Value US$823
3.6
Farid Adrienne Chief Operations Officer Officer
Transaction date
Sale
Price
1.23
Quantity 1,033 -0.8%
Value US$1,267
3.9
Carr Douglas SVP Finance & Operations Officer
Transaction date
Sale
Price
1.23
Quantity 283 -0.1%
Value US$347
3.6
Farid Adrienne Officer Officer
Transaction date
Proposed sale
Price
1.23
Quantity 1,033
Value US$1,268
2.1
Quimi Daphne Non-Executive Director
Transaction date
Purchase
Price
1.53
Quantity 5,000 +inf%
Value US$7,657
3.6
Farid Adrienne Chief Operations Officer Officer
Transaction date
Sale
Price
1.83
Quantity 1,073 -0.8%
Value US$1,960
3.9
Carr Douglas SVP Finance & Operations Officer
Transaction date
Sale
Price
1.83
Quantity 289 -0.1%
Value US$528
3.6
Farid Adrienne Officer Officer
Transaction date
Proposed sale
Price
1.83
Quantity 1,073
Value US$1,960
3.7
Russotti Gregory See Remarks Officer
Transaction date
Planned sale
Price
2.50
Quantity 586 -0.2%
Value US$1,465
3.7
Russotti Gregory Officer Officer
Transaction date
Proposed sale
Price
2.50
Quantity 586
Value US$1,465
3.7
Russotti Gregory See Remarks Officer
Transaction date
Planned sale
Price
2.52
Quantity 1,600 -0.6%
Value US$4,029
3.7
Russotti Gregory Officer Officer
Transaction date
Proposed sale
Price
2.52
Quantity 1,600
Value US$4,030
3.7
Russotti Gregory See Remarks Officer
Transaction date
Planned sale
Price
2.50
Quantity 200 -0.1%
Value US$500
3.7
Russotti Gregory Officer Officer
Transaction date
Proposed sale
Price
2.50
Quantity 200
Value US$500
3.7
Russotti Gregory See Remarks Officer
Transaction date
Planned sale
Price
2.84
Quantity 5,000 -1.8%
Value US$14,178
3.7
Russotti Gregory Officer Officer
Transaction date
Proposed sale
Price
2.84
Quantity 5,000
Value US$14,178
3.7
Russotti Gregory See Remarks Officer
Transaction date
Planned sale
Price
3.00
Quantity 5,000 -1.7%
Value US$14,989
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-05 2026-08-03 S Sale
3.9
Carr Douglas

SVP Finance & Operations

Officer
12,941 +46.3%
19.59
US$4,742,559 		12,941 +46.3% 19.59 US$4,742,559
2026-06-15 2026-06-12 S Sale
3.7
Russotti Gregory

See Remarks

Officer
87,296 +21.6%
277.88
US$1,966,921 		87,296 +21.6% 277.88 US$1,966,921
2026-06-15 2026-06-12 S Sale
3.9
Carr Douglas

SVP Finance & Operations

Officer
16,488 +24.1%
286.52
US$2,098,316 		16,488 +24.1% 286.52 US$2,098,316
2026-06-12 2026-06-12 PrS Proposed sale
3.7
Russotti Gregory

Officer

Officer
2,584
2.23
US$5,768 		2,584 2.23 US$5,768
2026-06-09 2026-06-08 S Sale
3.9
Carr Douglas

SVP Finance & Operations

Officer
249 -0.0%
2.11
US$526 		249 -0.0% 2.11 US$526
2026-06-09 2026-06-08 S Sale
3.9
Carr Douglas

SVP Finance & Operations

Officer
249 -0.0%
2.11
US$526 		249 -0.0% 2.11 US$526
2026-06-09 2026-06-08 S Sale
3.7
Russotti Gregory

See Remarks

Officer
524 -0.1%
2.11
US$1,106 		524 -0.1% 2.11 US$1,106
2026-06-08 2026-06-08 PrS Proposed sale
3.7
Russotti Gregory

Officer

Officer
524
2.11
US$1,106 		524 2.11 US$1,106
2026-05-06 2026-05-04 S Sale
3.9
Carr Douglas

SVP Finance & Operations

Officer
264 -0.1%
2.34
US$618 		264 -0.1% 2.34 US$618
2026-03-16 2026-03-12 S Sale
3.7
Russotti Gregory

See Remarks

Officer
10,076 -1.9%
2.55
US$25,684 		10,076 -1.9% 2.55 US$25,684
2026-03-16 2026-03-12 S Sale
3.9
Carr Douglas

SVP Finance & Operations

Officer
7,043 -1.4%
2.55
US$17,953 		7,043 -1.4% 2.55 US$17,953
2026-03-12 2026-03-12 PrS Proposed sale
3.7
Russotti Gregory

Officer

Officer
10,076
2.55
US$25,686 		10,076 2.55 US$25,686
2026-03-11 2026-03-09 S Sale
3.9
Carr Douglas

SVP Finance & Operations

Officer
247 -0.0%
2.54
US$626 		247 -0.0% 2.54 US$626
2026-03-11 2026-03-09 S Sale
3.7
Russotti Gregory

See Remarks

Officer
479 -0.1%
2.54
US$1,215 		479 -0.1% 2.54 US$1,215
2026-03-09 2026-03-09 PrS Proposed sale
3.7
Russotti Gregory

Officer

Officer
479
2.54
US$1,215 		479 2.54 US$1,215
2026-02-05 2026-02-03 S Sale
3.9
Carr Douglas

SVP Finance & Operations

Officer
323 -0.1%
1.82
US$589 		323 -0.1% 1.82 US$589
2025-12-29 2025-12-22 B Purchase
3.5
Cowan Chad

Chief Scientific Officer

Officer
58,060 +5.9%
0.85
US$49,252 		58,060 +5.9% 0.85 US$49,252
2025-12-16 2025-12-12 B Purchase
4.0
Pfeiffenberger Brent

President and CEO

Executive Director
52,000 +1.6%
0.58
US$30,352 		52,000 +1.6% 0.58 US$30,352
2025-12-10 2025-12-08 S Sale
3.7
Russotti Gregory

See Remarks

Officer
526 -0.1%
0.53
US$280 		526 -0.1% 0.53 US$280
2025-12-10 2025-12-08 S Sale
3.9
Carr Douglas

SVP Finance & Operations

Officer
257 -0.1%
0.53
US$137 		257 -0.1% 0.53 US$137
2025-12-08 2025-12-08 PrS Proposed sale
4.0
Pfeiffenberger Brent

Officer; Director

Executive Director
476
0.53
US$253 		476 0.53 US$253
2025-12-08 2025-12-08 PrS Proposed sale
3.7
Russotti Gregory

Officer

Officer
526
0.53
US$280 		526 0.53 US$280
2025-11-24 2025-11-20 S Sale
3.5
Cowan Chad

Chief Scientific Officer

Officer
5,462 -0.6%
0.50
US$2,736 		5,462 -0.6% 0.50 US$2,736
2025-11-20 2025-11-20 PrS Proposed sale
3.5
Cowan Chad

Officer

Officer
5,462
0.50
US$2,739 		5,462 0.50 US$2,739
2025-11-20 2025-11-19 B Purchase
4.0
Pfeiffenberger Brent

President and CEO

Executive Director
35,000 +1.1%
0.50
US$17,328 		35,000 +1.1% 0.50 US$17,328
2025-11-19 2025-11-17 S Sale
4.0
Pfeiffenberger Brent

President and CEO

Executive Director
32,456 -1.0%
0.45
US$14,735 		32,456 -1.0% 0.45 US$14,735
2025-11-17 2025-11-17 PrS Proposed sale
4.0
Pfeiffenberger Brent

Officer; Director

Executive Director
32,456
0.45
US$14,732 		32,456 0.45 US$14,732
2025-11-05 2025-11-03 S Sale
3.9
Carr Douglas

SVP Finance & Operations

Officer
292 -0.1%
0.59
US$171 		292 -0.1% 0.59 US$171
2025-09-10 2025-09-08 S Sale
3.9
Carr Douglas

SVP Finance & Operations

Officer
263 -0.1%
0.50
US$132 		263 -0.1% 0.50 US$132
2025-09-10 2025-09-08 S Sale
4.0
Pfeiffenberger Brent

President and CEO

Executive Director
488 -0.0%
0.50
US$244 		488 -0.0% 0.50 US$244
2025-09-10 2025-09-08 S Sale
3.7
Russotti Gregory

See Remarks

Officer
539 -0.1%
0.50
US$270 		539 -0.1% 0.50 US$270
2025-09-08 2025-09-08 PrS Proposed sale
4.0
Pfeiffenberger Brent

Officer; Director

Executive Director
488
0.50
US$244 		488 0.50 US$244
2025-09-08 2025-09-08 PrS Proposed sale
3.7
Russotti Gregory

Officer

Officer
539
0.50
US$269 		539 0.50 US$269
2025-08-18 2025-08-18 PrS Proposed sale
4.0
Pfeiffenberger Brent

Officer; Director

Executive Director
30,745
0.57
US$17,522 		30,745 0.57 US$17,522
2025-08-06 2025-08-04 S Sale
3.9
Carr Douglas

SVP Finance & Operations

Officer
296 -0.1%
0.53
US$158 		296 -0.1% 0.53 US$158
2025-06-11 2025-06-09 S Sale
4.0
Pfeiffenberger Brent

President and CEO

Executive Director
475 -0.0%
0.62
US$295 		475 -0.0% 0.62 US$295
2025-06-11 2025-06-09 S Sale
3.9
Carr Douglas

SVP Finance & Operations

Officer
4,904 -1.2%
0.62
US$3,050 		4,904 -1.2% 0.62 US$3,050
2025-06-11 2025-06-09 S Sale
3.6
Farid Adrienne

Chief Operations Officer

Officer
552 -0.2%
0.62
US$343 		552 -0.2% 0.62 US$343
2025-06-11 2025-06-09 S Sale
3.7
Russotti Gregory

See Remarks

Officer
526 -0.1%
0.62
US$327 		526 -0.1% 0.62 US$327
2025-06-09 2025-06-09 PrS Proposed sale
4.0
Pfeiffenberger Brent

Officer; Director

Executive Director
475
0.62
US$296 		475 0.62 US$296
2025-06-09 2025-06-09 PrS Proposed sale
3.6
Farid Adrienne

Officer

Officer
552
0.62
US$343 		552 0.62 US$343
2025-06-09 2025-06-09 PrS Proposed sale
3.7
Russotti Gregory

Officer

Officer
526
0.62
US$327 		526 0.62 US$327
2025-05-20 2025-05-16 S Sale
4.0
Pfeiffenberger Brent

President and CEO

Executive Director
29,552 -1.7%
0.55
US$16,135 		29,552 -1.7% 0.55 US$16,135
2025-05-16 2025-05-16 PrS Proposed sale
4.0
Pfeiffenberger Brent

Officer; Director

Executive Director
29,552
0.55
US$16,138 		29,552 0.55 US$16,138
2025-05-07 2025-05-05 S Sale
3.6
Farid Adrienne

Chief Operations Officer

Officer
1,024 -0.4%
0.55
US$563 		1,024 -0.4% 0.55 US$563
2025-05-07 2025-05-05 S Sale
3.9
Carr Douglas

SVP Finance & Operations

Officer
295 -0.1%
0.55
US$162 		295 -0.1% 0.55 US$162
2025-05-05 2025-05-05 PrS Proposed sale
3.6
Farid Adrienne

Officer

Officer
1,024
0.55
US$563 		1,024 0.55 US$563
2025-03-12 2025-03-10 S Sale
4.0
Pfeiffenberger Brent

President and CEO

Executive Director
2,235 -0.2%
0.62
US$1,375 		2,235 -0.2% 0.62 US$1,375
2025-03-12 2025-03-10 S Sale
3.6
Farid Adrienne

Chief Operations Officer

Officer
2,359 -1.8%
0.62
US$1,451 		2,359 -1.8% 0.62 US$1,451
2025-03-12 2025-03-10 S Sale
3.9
Carr Douglas

SVP Finance & Operations

Officer
1,240 -0.4%
0.62
US$763 		1,240 -0.4% 0.62 US$763
2025-03-12 2025-03-10 S Sale
3.7
Russotti Gregory

See Remarks

Officer
2,360 -0.9%
0.62
US$1,451 		2,360 -0.9% 0.62 US$1,451
2025-03-10 2025-03-10 PrS Proposed sale
4.0
Pfeiffenberger Brent

Officer; Director

Executive Director
2,235
0.62
US$1,375 		2,235 0.62 US$1,375
2025-03-10 2025-03-10 PrS Proposed sale
3.7
Russotti Gregory

Officer

Officer
2,360
0.62
US$1,452 		2,360 0.62 US$1,452
2025-03-10 2025-03-10 PrS Proposed sale
3.6
Farid Adrienne

Officer

Officer
2,359
0.62
US$1,451 		2,359 0.62 US$1,451
2025-02-20 2025-02-18 S Sale
4.0
Pfeiffenberger Brent

President and CEO

Executive Director
34,712 -2.8%
0.78
US$27,179 		34,712 -2.8% 0.78 US$27,179
2025-02-18 2025-02-18 PrS Proposed sale
4.0
Pfeiffenberger Brent

Officer; Director

Executive Director
34,712
0.78
US$27,166 		34,712 0.78 US$27,166
2025-02-05 2025-02-03 S Sale
3.9
Carr Douglas

SVP Finance & Operations

Officer
351 -0.1%
0.78
US$274 		351 -0.1% 0.78 US$274
2025-02-05 2025-02-03 S Sale
3.6
Farid Adrienne

Chief Operations Officer

Officer
1,054 -0.8%
0.78
US$822 		1,054 -0.8% 0.78 US$822
2025-02-03 2025-02-03 PrS Proposed sale
3.6
Farid Adrienne

Officer

Officer
1,054
0.78
US$823 		1,054 0.78 US$823
2024-11-05 2024-11-04 S Sale
3.6
Farid Adrienne

Chief Operations Officer

Officer
1,033 -0.8%
1.23
US$1,267 		1,033 -0.8% 1.23 US$1,267
2024-11-05 2024-11-04 S Sale
3.9
Carr Douglas

SVP Finance & Operations

Officer
283 -0.1%
1.23
US$347 		283 -0.1% 1.23 US$347
2024-11-04 2024-11-04 PrS Proposed sale
3.6
Farid Adrienne

Officer

Officer
1,033
1.23
US$1,268 		1,033 1.23 US$1,268
2024-09-16 2024-09-12 B Purchase
2.1
Quimi Daphne
Non-Executive Director
5,000 +inf%
1.53
US$7,657 		5,000 +inf% 1.53 US$7,657
2024-08-07 2024-08-05 S Sale
3.6
Farid Adrienne

Chief Operations Officer

Officer
1,073 -0.8%
1.83
US$1,960 		1,073 -0.8% 1.83 US$1,960
2024-08-07 2024-08-05 S Sale
3.9
Carr Douglas

SVP Finance & Operations

Officer
289 -0.1%
1.83
US$528 		289 -0.1% 1.83 US$528
2024-08-05 2024-08-05 PrS Proposed sale
3.6
Farid Adrienne

Officer

Officer
1,073
1.83
US$1,960 		1,073 1.83 US$1,960
2024-07-31 2024-07-26 PlS Planned sale
3.7
Russotti Gregory

See Remarks

Officer
586 -0.2%
2.50
US$1,465 		586 -0.2% 2.50 US$1,465
2024-07-26 2024-07-26 PrS Proposed sale
3.7
Russotti Gregory

Officer

Officer
586
2.50
US$1,465 		586 2.50 US$1,465
2024-07-25 2024-07-24 PlS Planned sale
3.7
Russotti Gregory

See Remarks

Officer
1,600 -0.6%
2.52
US$4,029 		1,600 -0.6% 2.52 US$4,029
2024-07-24 2024-07-24 PrS Proposed sale
3.7
Russotti Gregory

Officer

Officer
1,600
2.52
US$4,030 		1,600 2.52 US$4,030
2024-07-25 2024-07-23 PlS Planned sale
3.7
Russotti Gregory

See Remarks

Officer
200 -0.1%
2.50
US$500 		200 -0.1% 2.50 US$500
2024-07-23 2024-07-23 PrS Proposed sale
3.7
Russotti Gregory

Officer

Officer
200
2.50
US$500 		200 2.50 US$500
2024-06-24 2024-06-20 PlS Planned sale
3.7
Russotti Gregory

See Remarks

Officer
5,000 -1.8%
2.84
US$14,178 		5,000 -1.8% 2.84 US$14,178
2024-06-20 2024-06-20 PrS Proposed sale
3.7
Russotti Gregory

Officer

Officer
5,000
2.84
US$14,178 		5,000 2.84 US$14,178
2024-06-06 2024-06-05 PlS Planned sale
3.7
Russotti Gregory

See Remarks

Officer
5,000 -1.7%
3.00
US$14,989 		5,000 -1.7% 3.00 US$14,989
Explore more

More insider trading research around Century Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America